Effectiveness and safety of biologics in the treatment of severe chronic rhinosinusitis with polyposis (CRSwNP): real-world data
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S315
DOI: 10.1055/s-0044-1785064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Nadine Gunder und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
In the past years, three monoclonal antibodies have been approved in Germany for the treatment of the severe form of CRSwNP. This study investigated the effectiveness and safety of dupilumab, omalizumab and mepolizumab in clinical use. Material & Methods To date, 93 adults with severe CRSwNP and inadequate response to intranasal corticosteroids have been treated with dupilumab (n=63), mepolizumab (n=7) or omalizumab (n=23) at our clinic. The observation period was up to 24 months (11/2019-11/2023). Nasal polyp score (NPS), quality of life (QoL, SNOT-22) and olfactory function (OF, Sniffin' Sticks threshold and identification test) were assessed initially, after one, 6, 12, 18 and 24 months. The changes in each parameter compared to baseline were analysed.
Results
Biologic therapy showed a significant improvement (p
Zitieren
APA
Gunder, N., Hummel, T., & Cuevas, M. (2024). Effectiveness and safety of biologics in the treatment of severe chronic rhinosinusitis with polyposis (CRSwNP): real-world data. Laryngo-Rhino-Otologie, 103(S 02 S 02), S315. https://doi.org/10.1055/s-0044-1785064
Vancouver
Gunder N, Hummel T, Cuevas M. Effectiveness and safety of biologics in the treatment of severe chronic rhinosinusitis with polyposis (CRSwNP): real-world data. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S315. doi:10.1055/s-0044-1785064
BibTeX
@article{Gunder2024,
author = {Gunder, Nadine and Hummel, Thomas and Cuevas, Mandy},
title = {Effectiveness and safety of biologics in the treatment of severe chronic rhinosinusitis with polyposis (CRSwNP): real-world data},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S315},
doi = {10.1055/s-0044-1785064}
}
EUVIMED